Schedule 13G ownership disclosure
UNICYCIVE THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 90466Y103
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 1,855,991.00 · Class: 9.99%
- Wilmot B. Harkey
Shares: 1,855,991.00 · Class: 9.99%
- Daniel Mack
Shares: 1,855,991.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-112646
- Form type
- SCHEDULE 13G/A
- Filer
- Nantahala Capital Management, LLC
- CIK
- CIK 1472322
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership